← Back to Search

Behavioural Intervention

TrueRelief device for Rotator Cuff Tendinitis

N/A
Waitlist Available
Led By Vandana Sood, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up beginning of study (visit 1 - week 1), midpoint of study (visit 5 - week 2), end of study (visit 9 - week 3), 1-month post-treatment follow-up call (week 7-9)
Awards & highlights

Study Summary

This trial is testing if a new device, TrueRelief, can help improve shoulder pain for patients. The investigators think that patients with fewer medical problems will see the most improvement.

Eligible Conditions
  • Rotator Cuff Tendinitis
  • Shoulder Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~beginning of study (visit 1 - week 1), midpoint of study (visit 5 - week 2), end of study (visit 9 - week 3), 1-month post-treatment follow-up call (week 7-9)
This trial's timeline: 3 weeks for screening, Varies for treatment, and beginning of study (visit 1 - week 1), midpoint of study (visit 5 - week 2), end of study (visit 9 - week 3), 1-month post-treatment follow-up call (week 7-9) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in pain measurements in patients with Supraspinatus Tendonitis (SST).
Secondary outcome measures
Change in perceived shoulder function as measured by QuickDASH Questionnaire in patients with Supraspinatus Tendonitis (SST).
Change in perceived shoulder function as measured by a Shoulder Rating Questionnaire in patients with Supraspinatus Tendonitis (SST).

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ExperimentalExperimental Treatment1 Intervention
Patients receive an experimental procedure using a TrueRelief device.
Group II: PlaceboPlacebo Group1 Intervention
Patients receive a placebo procedure using a sham TrueRelief device that looks and operates identically to the experimental TrueRelief device but will not emit any high frequency current.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TrueRelief device
2022
N/A
~140

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,054 Previous Clinical Trials
1,316,528 Total Patients Enrolled
TrueRelief, LLCUNKNOWN
1 Previous Clinical Trials
134 Total Patients Enrolled
Vandana Sood, MDPrincipal InvestigatorWeill Medical College of Cornell University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I potentially qualify for this clinical experiment?

"30 people with a maximum of 3 months' worth of shoulder pain can be admitted to this clinical trial. Eligible applicants must fall within the age range of 18-65 years old and meet all other criteria established by our team at Power."

Answered by AI

Is this study open to those of advanced age, i.e., over sixty years?

"The current protocol requires that participants be between 18 to 65 years of age. There are 14 separate trials for minors, and 186 distinct studies for senior citizens."

Answered by AI

What is the upper limit of participants in this scientific experiment?

"Correct. The information available from clinicaltrials.gov reflects that this research project, which was first published on May 4th 2022, is still enrolling candidates. 30 participants should be enrolled at a single trial site."

Answered by AI

Is this research currently accepting participants?

"Yes, the records available on clinicaltrials.gov demonstrate that this trial is open to new participants. Initially posted in May of 2022 and most recently modified 24th June, it seeks 30 patients from a single site."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
New York Presbyterian/Weill Cornell Medical Center Rehabilitation Medicine
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
TrueRelief Efficacy for Supraspinatus Tendonitis
2022. "TrueRelief Efficacy for Supraspinatus Tendonitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05184985.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top